Efficacy, safety, and patient acceptability of elvitegravir/cobicistat/emtricitabine/tenofovir in the treatment of HIV/AIDS by Prinapori R, Di Biagio A

Get full text

Cost-effectiveness analysis of initial HIV treatment under Italian guidelines by Viale P, Viscoli C, Di Matteo S, Di Biagio A, Colangeli V, Colombo GL

Get full text

Cost per care of the first year of direct antiviral agents in the Liguria Region: a multicenter analysis by Cenderello G, Fanizza C, Marenco S, Nicolini LA, Artioli S, Baldissarro I, Dentone C, De Leo P, Di Biagio A

Get full text

Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: a multicenter regional simulation by Cenderello G, Artioli S, Viscoli C, Pasa A, Giacomini M, Giannini B, Dentone C, Nicolini LA, Cassola G, Di Biagio A

Get full text

General Practitioners as partners for a shared management of chronic HIV infection: an insight into the perspectives of Italian people living with HIV by Bruno, SR, Poliseno, M, Vichi, F, Esperti, S, Di Biagio, A, Berruti, M, Ferrara, S, Pisani, L, Saracino, A, Santantonio, TA, Lo Caputo, S

The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile by Squillace N, Ricci E, Menzaghi B, De Socio GV, Passerini S, Martinelli C, Mameli MS, Maggi P, Falasca K, Cordier L, Celesia BM, Salomoni E, Di Biagio A, Pellicanò GF, Bonfanti P

Get full text

Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA Project by Bagella P, De Socio GVL, Ricci E, Menzaghi B, Martinelli C, Squillace N, Maggi P, Orofino G, Calza L, Carenzi L, Celesia BM, Penco G, Di Biagio A, Valsecchi L, Vichi F, Colombo V, Parruti G, Dentone C, Falasca K, Bonfanti P, Madeddu G

Get full text